MariMed Commences Adult-Use Sales at Thrive Wellness Dispensary in Tiffin, Ohio
MariMed Inc. (CSE: MRMD) (OTCQX: MRMD) has launched adult-use retail sales at its Thrive Wellness dispensary in Tiffin, Ohio. The dispensary, which opened in June 2023 as a medical-only facility, now offers a wide range of branded flower and edible products to both medical and recreational customers.
CEO Jon Levine expressed enthusiasm for the expansion, stating that Ohio is expected to become one of the largest cannabis markets in the country. MariMed is prioritizing Ohio in its mergers and acquisitions strategy to become a vertical operator as quickly as possible.
Ohio's medical marijuana industry generated nearly $500 million in retail sales in 2023, with significant growth anticipated following the introduction of adult-use sales. As the seventh most populous state in the U.S. with 11.8 million residents, Ohio presents a substantial market opportunity for cannabis operators like MariMed.
MariMed Inc. (CSE: MRMD) (OTCQX: MRMD) ha avviato le vendite retail per uso adulto presso il suo dispensario Thrive Wellness a Tiffin, Ohio. Il dispensario, aperto nel giugno 2023 come struttura esclusivamente medicinale, ora offre un'ampia gamma di prodotti di fiori e commestibili a clienti sia medici che ricreativi.
Il CEO Jon Levine ha espresso entusiasmo per l'espansione, affermando che l'Ohio è previsto diventare uno dei più grandi mercati di cannabis nel paese. MariMed sta dando priorità all'Ohio nella sua strategia di fusioni e acquisizioni per diventare un operatore verticale il più rapidamente possibile.
L'industria della marijuana medica in Ohio ha generato quasi 500 milioni di dollari in vendite retail nel 2023, con una crescita significativa attesa dopo l'introduzione delle vendite per uso adulto. Essendo il settimo stato più popoloso degli Stati Uniti con 11,8 milioni di residenti, l'Ohio rappresenta un'opportunità di mercato sostanziale per operatori di cannabis come MariMed.
MariMed Inc. (CSE: MRMD) (OTCQX: MRMD) ha comenzado las ventas minoristas de uso adulto en su dispensario Thrive Wellness en Tiffin, Ohio. El dispensario, que abrió en junio de 2023 como una instalación exclusivamente médica, ahora ofrece una amplia gama de productos de flores y comestibles a clientes tanto médicos como recreativos.
El CEO Jon Levine expresó entusiasmo por la expansión, afirmando que se espera que Ohio se convierta en uno de los mercados de cannabis más grandes del país. MariMed está priorizando Ohio en su estrategia de fusiones y adquisiciones para convertirse en un operador vertical lo antes posible.
La industria de la marihuana medicinal en Ohio generó casi 500 millones de dólares en ventas minoristas en 2023, con un crecimiento significativo anticipado tras la introducción de las ventas para uso adulto. Siendo el séptimo estado más poblado de EE. UU. con 11.8 millones de residentes, Ohio presenta una oportunidad de mercado sustancial para operadores de cannabis como MariMed.
마리메드 Inc. (CSE: MRMD) (OTCQX: MRMD)가 오하이오주 티핀에 위치한 Thrive Wellness 매장에서 성인용 소매 판매를 시작했습니다. 2023년 6월에 의료 전용 시설로 열린 이 매장은 이제 의료 및 레크리에이션 고객 모두에게 다양한 브랜드의 꽃과 식용 제품을 제공합니다.
CEO인 존 레빈은 확장에 대한 열정을 표현하며 오하이오가 미국에서 가장 큰 대마초 시장 중 하나로 성장할 것으로 예상된다고 전했습니다. 마리메드는 가능한 한 빨리 수직 운영자가 되기 위해 인수 합병 전략에서 오하이오에 우선순위를 두고 있습니다.
오하이오의 의료 대마초 산업은 2023년에 5억 달러에 가까운 소매 판매를 기록했습니다, 성인용 판매 도입 이후 상당한 성장이 예상됩니다. 미국에서 일곱 번째로 인구가 많은 주인 오하이오(인구 1,180만명)는 마리메드와 같은 대마초 운영자에게 상당한 시장 기회를 제공합니다.
MariMed Inc. (CSE: MRMD) (OTCQX: MRMD) a lancé les ventes au détail à usage adulte dans son dispensaire Thrive Wellness à Tiffin, Ohio. Le dispensaire, qui a ouvert en juin 2023 en tant qu'établissement exclusivement médical, propose désormais une large gamme de fleurs et de produits comestibles de marque aux clients médicaux et récréatifs.
Le PDG Jon Levine a exprimé son enthousiasme pour cette expansion, affirmant que l'Ohio devrait devenir l'un des plus grands marchés de cannabis du pays. MariMed privilégie l'Ohio dans sa stratégie de fusions et d'acquisitions pour devenir un opérateur vertical le plus rapidement possible.
L'industrie du marijuana médical en Ohio a généré près de 500 millions de dollars de ventes au détail en 2023, avec une croissance significative prévue après l'introduction des ventes à usage adulte. En tant que septième État le plus peuplé des États-Unis avec 11,8 millions d'habitants, l'Ohio représente une opportunité de marché substantielle pour des opérateurs de cannabis comme MariMed.
MariMed Inc. (CSE: MRMD) (OTCQX: MRMD) hat den Einzelhandel für erwachsene Käufer in seinem Thrive Wellness-Dispensary in Tiffin, Ohio, gestartet. Das Dispensing, das im Juni 2023 als ausschließlich medizinische Einrichtung eröffnet wurde, bietet jetzt eine breite Palette an markenbezogenen Blüten und essbaren Produkten für medizinische sowie Freizeitanwender an.
CEO Jon Levine äußerte seine Begeisterung über die Expansion und erklärte, dass Ohio voraussichtlich einer der größten Cannabis-Märkte des Landes werden wird. MariMed priorisiert Ohio in seiner Strategie für Fusionen und Übernahmen, um so schnell wie möglich ein vertikaler Betreiber zu werden.
Die medizinische Marihuana-Industrie in Ohio erzielte im Jahr 2023 fast 500 Millionen Dollar an Einzelhandelsumsätzen, wobei nach der Einführung des Verkaufs für Erwachsene ein signifikantes Wachstum erwartet wird. Da Ohio der siebtbevölkerungsreichste Staat in den USA mit 11,8 Millionen Einwohnern ist, bietet es eine erhebliche Marktchance für Cannabis-Betreiber wie MariMed.
- Expansion into adult-use sales in Ohio, potentially increasing revenue
- Ohio's cannabis market generated nearly $500 million in medical sales in 2023
- Ohio is the seventh most populous state, offering a large potential customer base
- Company prioritizing mergers and acquisitions to become a vertical operator in Ohio
- None.
NORWOOD, Mass., Sept. 24, 2024 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed”) (CSE: MRMD) (OTCQX: MRMD), a leading multi-state cannabis operator focused on improving lives every day, today announced it has commenced adult-use retail sales at its Thrive Wellness dispensary in Tiffin, Ohio.
Since its opening in June 2023, the dispensary has been operating as a medical-only facility, offering a diverse selection of branded flower and edible products from across the state.
“We are thrilled to commence adult-use sales in Ohio,” said Jon Levine, MariMed’s Chief Executive Officer. “We have long believed that Ohio will be one of the country’s largest cannabis markets, and it remains our top priority with respect to mergers and acquisitions to become a vertical operator as quickly as possible.”
According to the Ohio Department of Commerce, Ohio’s medical marijuana industry generated nearly
About MariMed
MariMed Inc, a multi-state cannabis operator, is dedicated to improving lives every day through its high-quality products, its actions, and its values. The Company develops, owns, and manages seed to sale state-licensed cannabis facilities, which are models of excellence in horticultural principles, cannabis cultivation, cannabis-infused products, and dispensary operations. MariMed has an experienced management team that has produced consistent growth and success for the Company and its managed business units. Proprietary formulations created by the Company’s technicians are embedded in its top-selling and award-winning products and brands, including Betty's Eddies™, Nature’s Heritage™, InHouse™, Bubby’s Baked™, K Fusion™, Kalm Fusion™, and Vibations™. For additional information, visit www.marimedinc.com.
IMPORTANT CAUTION REGARDING FORWARD-LOOKING STATEMENTS:
The information in this release contains “forward-looking” statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, which are subject to several risks and uncertainties. All statements other than statements of historical facts contained in this release, including without limitation statements regarding projected financial results for 2024, including management’s belief that it will report its fifth consecutive year of positive operating cash flow, anticipated openings of dispensaries and facilities, timing of regulatory approvals, plans and objectives of management for future operations, are forward-looking statements. Without limiting the foregoing, the words “anticipates”, “believes”, “estimates”, “expects”, “expectations”, “intends”, “may”, “plans”, and other similar language, whether in the negative or affirmative, are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words.
Forward-looking statements are based on our current beliefs and assumptions regarding our business, timing of regulatory approvals, the ability to obtain new licenses, business prospects and strategic growth plan, and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. Our actual results may differ materially from those contemplated in these forward-looking statements due to various risks, uncertainties, and other important factors, including, among others, reductions in customer spending, our ability to recruit and retain key personnel, and disruptions from the integration efforts of acquired companies.
These factors are not intended to be an all-encompassing list of risks and uncertainties that may affect our business and results of operations. These statements are not a guarantee of future performance and involve risk and uncertainties that are difficult to predict, including, among other factors, changes in demand for the Company’s services and products, changes in the law and its enforcement, and changes in the economic environment. Additional information regarding these and other factors can be found in our reports filed with the U.S. Securities and Exchange Commission. In providing these forward-looking statements, the Company expressly disclaims any obligation to update these statements publicly or otherwise, whether as a result of new information, future events or otherwise, except as required by law.
All trademarks and service marks are the property of their respective owners.
Company Contact:
Howard Schacter
Chief Communications Officer
Email: hschacter@marimedinc.com
Phone: (781) 277-0007
Investor Relations Contact:
Steve West
Vice President, Investor Relations
Email: ir@marimedinc.com
Phone: (781) 277-0007
FAQ
When did MariMed (MRMD) start adult-use sales at its Tiffin, Ohio dispensary?
How much did Ohio's medical marijuana industry generate in retail sales in 2023?
What is MariMed's (MRMD) expansion strategy in Ohio?
When did MariMed's (MRMD) Thrive Wellness dispensary in Tiffin, Ohio originally open?
